ARCHIVES

Spending Freeze Could Harm Medical Research, ACS Advocacy Affiliate Says

This article is from The Cancer Letter archive.

Vol. 36 No. 03 | January 29, 2010

Download PDF Visit The Full Archive

Related Articles

Zaltrap Price Cut In Half Effective Immediately

November 8, 2012

Gleevec First Pediatric Cancer Approval By FDA In 13 Years

May 30, 2003

Wynder, Weinburg Head Recipients Of Milken Awards

December 14, 1990

In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President

October 16, 1981

In Brief: NCAB Objects To Low Priority For Several Cancer Control Grants, Asks For New Review

June 22, 1979

Anil Potti Resigns From Duke University

November 19, 2010